Map of Florida with a pill bottle displaying a maple leaf. As it peels away, the label shows a poison symbol

Decision on Florida’s importation program delayed

October 24, 2023

A delay in Florida’s response to FDA questions means the agency’s decision won’t be by October 31 after all.

Read More
Google search results for retatrutide

October 23, 2023: Even drugs in development are at risk for counterfeiting

October 23, 2023

Sketchy online vendors are selling “retatrutide” even though it’s still in clinical trials. A man who sold U.S. pharmacies secondhand prescription medicines was sentenced. Domestic and international stories about fake drugs.

Read More
a comparison of real and fake Ozempic pens sold in Germany.

October 16, 2023: More fake Ozempic appears in the EU

October 16, 2023

Almost 200 packages of fake Ozempic traveled from Austria to the U.K. via Germany. An 11th man was sentenced in a $52mm cough medicine counterfeiting scheme. Europol reports the seizure of medical products. Additional news about pill presses in Mexico and the U.S.

Read More
Label for a barrel of sodium chlorite powder with warning labels advising the product was toxic.

October 9, 2023: Florida conmen who sold industrial bleach as a COVID cure sentenced to federal prison

October 9, 2023

The leaders of the “Genesis II Church of Health and Healing” received a cumulative 34 years in prison. A NYC pharmacist pleaded guilty to fraud and money laundering after selling black market HIV drugs. Pill press operations busted in NYC and Rhode Island.

Read More

October 2, 2023: After deaths overseas, the FDA is working to protect Americans from toxic cough syrup.

October 2, 2023

The FDA is cracking down on lax safety testing of raw drug ingredients. Major players in HIV drug and cough syrup counterfeiting schemes pleaded guilty in federal court.

Counterfeit Avastin in Pakistan blinded over 70 retinopathy patients.

CBP at JFK Airport intercepted 14 pairs of pill press dies. Additional news about illicit pill presses in five states.

Read More

PSM Executive Director to Speak at USPTO Roundtable on Counterfeits

September 20, 2023

Shabbir Imber Safdar, executive director of the Partnership for Safe Medicines, will participate in the upcoming United States Patent and Trademark Office Roundtable: Future strategies in anti-counterfeiting and anti-piracy.

Read More

September 18, 2023: USFDA concerned that eight companies, including two pharmacies, are illegally marketing unapproved ophthalmic drug products

September 18, 2023

USFDA is concerned that eight companies, including two pharmacies, are illegally marketing unapproved ophthalmic drug products that pose a heightened risk to users. Counterfeit pills make the DHS’ threat assessment list for 2024.

Read More

PSM and ADAP Advocacy call for more awareness about counterfeit medicines

September 15, 2023

Data recently shared in the Morbidity and Mortality Weekly Report highlights a growing problem: Counterfeit pill availability is rising in the drug supply chain, but also the illicit drug market.

Read More

Teach Your Community With These Conference Slides

September 13, 2023

Running slides between conference sessions and during breaks is a great way to fit in a little extra information. Use these slides to teach your community about counterfeit medicines in the U.S.

Read More

September 11, 2023: Global fake medicine trade’s scope revealed by incidents in U.K., India, Turkey and elsewhere

September 11, 2023

A U.K. couple was sentenced for selling 65 different brands of unapproved medicines. Counterfeit therapeutic medicines reported in India, Turkey and Pakistan. News about counterfeit pills made of dangerous substances in 13 states

Read More